AstraZeneca makes deal with White House to lower drug prices
AstraZeneca agreed to tie Medicaid drug prices to lower international rates, offer up to 80% direct-to-consumer discounts via TrumpRx, and expand U.S. operations.
TrumpRx makes more drug pricing moves and strikes a deal with AstraZeneca
AstraZeneca will offer U.S. patients lower prescription prices via a most-favored-nation policy and invest $50 billion in U.S. R&D and manufacturing over five years.
